Capital Research Global Investors’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-541,645
Closed -$15.3M 443
2021
Q1
$15.3M Sell
541,645
-590,355
-52% -$18.8M ﹤0.01% 401
2020
Q4
$36.2M Hold
1,132,000
0.01% 357
2020
Q3
$36.6M Hold
1,132,000
0.01% 342
2020
Q2
$31.2M Hold
1,132,000
0.01% 353
2020
Q1
$20.2M Hold
1,132,000
0.01% 342
2019
Q4
$28.4M Buy
1,132,000
+67,000
+6% +$1.47M 0.01% 356
2019
Q3
$19M Buy
+1,065,000
New +$22.2M 0.01% 369

Other funds holding HCM

Capital Research Global Investors's HCM Position: Q2 2021 in Review

Capital Research Global Investors sold out of HUTCHMED (HCM) in Q2 2021, closing a stake of 541,645 shares — an estimated $15.3M sold.

Capital Research Global Investors first reported a position in HCM in Q3 2019 and held it in 7 quarters. The position peaked at $36.6M in Q3 2020. 146 funds tracked by Wall St. Rank hold HCM as of Q2 2021.

  • Capital Research Global Investors reported no remaining HUTCHMED position as of Q2 2021 after selling out during the quarter.
  • Capital Research Global Investors sold 541,645 HUTCHMED shares in Q2 2021, an estimated $15.3M.
  • Capital Research Global Investors first reported a position in HUTCHMED in Q3 2019 and held it in 7 quarters.
  • Capital Research Global Investors's HUTCHMED position peaked at $36.6M in Q3 2020.
  • 146 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2021.

Based on Capital Research Global Investors's 13F filing for Q2 2021, filed 16 Aug 2021.